IndiaOne Finance - Company Dashboard

Governance Classic Home

Panacea Biotec LtdPharmaceuticalsINE922B01023Consolidated₹367.90-4.10 (-1.10%)Jun-26

Valuation

Market Cap₹2.25K Cr

TTM PE-317.16x

Forward PE248.58x

PEG-9.97

Book Value₹136.30

P/B2.70x

TTM EPS₹-1.16

Fwd EPS₹1.48

TTM Revenue₹672.64 Cr

TTM PAT₹-8.92 Cr

TTM EBITDA₹2.19 Cr

TTM EBIT₹-30.38 Cr

Last Qtr PAT₹2.20 Cr

Last Qtr EBITDA₹5.67 Cr

Last Qtr EBIT₹-2.23 Cr

Profitability

ROE-1.07%

ROCE1.77%

TTM NPM-1.33%

TTM EBITDA %0.33%

Curr OPM1.08%

Last OPM-0.59%

Curr NPM—

Last NPM—

Curr EPS₹0.38

Last EPS₹0.08

Balance sheet

Equity₹6.13 Cr

Reserve₹828.71 Cr

Total Debt₹23.66 Cr

D/E0.03x

Interest %53.64%

Curr Interest₹1.18 Cr

Price / range

Close₹367.90

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-1.10%

1W-7.48%

1M-9.35%

3M-31.21%

6M+7.78%

1Y-17.40%

2Y+5.86%

3Y+123.10%

5Y+23.68%

Diwali-2.67%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	134.71+20.0%	111.12	99.31	90.81	112.25	413.49
Other Income	6.06	5.60	3.84	3.61	4.95	18
Total Income	140.77+20.1%	116.72	103.15	94.42	117.20	431.49
Interest	6.89	6.33	7.04	5.93	6	25.30
Expenditure	-138.77-10.1%	-121.33	-112.62	-115.35	-126.04	-475.34
PBDT	0	0	0	0	0	0
EBITDA	7.30+341.7%	0.30	-1.38	-13.70	-3.02	-17.80
Depreciation	-4.47	-4.18	-4.89	-4.91	-4.77	-18.75
EBIT	2.83+136.3%	-3.88	-6.27	-18.61	-7.79	-36.55
PBT	2+122.6%	-4.61	-9.47	-20.93	-8.84	-43.85
Tax	-0.61	4.43	2.11	5.29	2.14	13.97
Equity	6.13	6.13	0	0	6.13	6.13
OPM	1.42	-3.95	-9.54	-23.05	-7.54	-10.16
Net Profit	1.39+120.7%	-0.18	-7.36	-15.64	-6.70	-29.88
NPM	0.99	-0.15	-7.41	-17.22	-5.72	-6.92
EPS	0.23+121.1%	-0.03	-1.20	-2.55	-1.09	4.88

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	413.49+33.4%	309.85-13.8%	359.60+39.9%	257.07+9.2%	235.50-31.5%	343.56
Other Income	18	16.62	24.91	34.43	12.57	20.74
Total Income	431.49+32.2%	326.47-15.1%	384.51+31.9%	291.50+17.5%	248.07-31.9%	364.30
Expenditure	-475.34-34.8%	-352.53+7.3%	-380.30-7.4%	-354.25-3.7%	-341.65+9.4%	-377.15
Interest	-25.30	-15.46	-13.78	-10.06	-7.04	-7.52
PBDT	0	0	0	0	0	0
EBITDA	-17.80-156.9%	-6.93-148.9%	14.17+122.6%	-62.62+13.8%	-72.68-14636.0%	0.50
Depreciation	-18.75	-20.29	-21.09	-24.50	-26.43	-26.57
EBIT	-36.55-34.3%	-27.22-293.4%	-6.92+92.1%	-87.12+12.1%	-99.11-280.2%	-26.07
PBT	-43.85-68.3%	-26.06-719.0%	4.21+106.7%	-62.75+32.9%	-93.58-628.2%	-12.85
Tax	13.97	10.83	-0.66	-24.79	0	-1.56
Equity	6.13	6.13	0	0	0	0
OPM (%)	-10.16	-7.98	1.00	-22.00	-38.00	-4.00
Net Profit	-29.88-96.2%	-15.23-529.0%	3.55+104.1%	-87.54+6.5%	-93.58-548.1%	-14.44
NPM (%)	-6.92	-4.67	1.00	-30.00	-38.00	-4.00
EPS (Rs)	0	0-100.0%	0.58+104.1%	-14.29+6.5%	-15.28-550.2%	-2.35
CEPS	4.88	0	0.58	-14.29	-15.28	-2.35

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	199.57+19.7%	166.75	165.19	141.13	166.70	639.77
Other Income	4.24	2.55	2.28	6.40	5.67	16.90
Total Income	203.81+18.2%	169.30	167.47	147.53	172.37	656.67
Interest	1.18	1.20	1.85	2.14	0.86	6.05
Expenditure	-202.98-14.6%	-173.26	-163.75	-169.40	-177.13	-683.54
PBDT	0	0	0	0	0	0
EBITDA	5.67+580.5%	2.57	11.74	-17.79	-1.18	-4.66
Depreciation	-7.90	-7.88	-8.45	-8.34	-8.39	-33.06
EBIT	-2.23+76.7%	-5.31	3.29	-26.13	-9.57	-37.72
PBT	3.57-45.6%	-1.25	6.49	0	6.56	-7.37
Tax	-1.37	0.25	-2.60	5.16	-2.60	0.21
Equity	6.13	6.13	0	0	6.13	6.13
OPM	1.75	-0.74	3.88	0.00	3.81	-1.12
Net Profit	2.20-44.4%	-1	3.89	-14.01	3.96	-7.16
NPM	1.08	-0.59	2.32	-9.50	2.30	-1.09
EPS	0.38-42.4%	0.08	0.65	-2.27	0.66	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	639.77+14.4%	559.090.0%	559.17+21.6%	459.95-30.4%	661.23+5.8%	624.81
Other Income	16.90	20.66	25.80	51.66	10.97	9.98
Total Income	656.67+13.3%	579.75-0.9%	584.97+14.3%	511.61-23.9%	672.20+5.9%	634.79
Expenditure	-683.54-9.6%	-623.69-0.7%	-619.52-3.0%	-601.47+33.1%	-899.59-15.5%	-779.11
Interest	-6.05	-3.88	-3.58	-4.44	-180.84	-185.34
PBDT	0	0	0	0	0	0
EBITDA	-4.66+82.0%	-25.91-29.2%	-20.06+79.5%	-97.96-606.8%	-13.86-118.1%	76.64
Depreciation	-33.06	-34.81	-36.71	-39.12	-43.66	-45.60
EBIT	-37.72+37.9%	-60.72-7.0%	-56.77+58.6%	-137.08-138.3%	-57.52-285.3%	31.04
PBT	-7.37+7.3%	-7.95-637.2%	1.48-88.4%	12.80-99.1%	1,448.82+1103.9%	-144.32
Tax	0.21	-0.77	-2.98	-46.55	-370.91	-1.96
Equity	6.13	6.13	0	0	0	0
OPM (%)	-1.12	-1.37	0.25	2.50	215.53	-22.74
Net Profit	-7.16+17.9%	-8.72-481.3%	-1.50+95.6%	-33.75-103.1%	1,077.91+830.0%	-147.65
NPM (%)	-1.09	-1.50	-0.26	-6.60	160.36	-23.26
EPS (Rs)	0	0+100.0%	-0.19+96.6%	-5.51-103.1%	175.98+829.9%	-24.11
CEPS	0	0	-0.19	-5.51	175.98	-24.11

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2011	Final Dividend	0.75	19 Sep 2011
2010	Final Dividend	0.25	16 Sep 2010
2008	Final Dividend	1	19 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split